Johnson & Johnson is to stop selling its popular baby talcum powder in the US and Canada as it faces legal action over claims it can cause cancer.
It plans to wind down sales of the product, which makes up about 0.5% of its consumer health business in the US, in the coming months with shops still selling their current stock.
However it will continue to be sold in the UK and other countries around the world. The US company said the decision was taken following an assessment of the products on sale in North America in light of the coronavirus pandemic.
But Johnson & Johnson faces more than 16,000 lawsuits from customers who claim its talcum products, including Johnson's Baby Powder, caused their cancer as they were contaminated with